longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Pomdoctor

POM

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.19, above the reasonable range, cheaper than 4.96% of the time in the past 1 years, and the industry ranks 7/14, the industry Median -0.19.

-0.186xP/E
$0.74Stock price
$-4.00Earnings per share
-0.186xP/E
Stock price$0.74Earnings per share$-4.00

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.54x
Typical range
-6.30x–-0.36x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
09182736

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x10x20x30x40x50x
P/E ratio
Name/Symbol
AHCOUSAdaptHealth
-3.50x145.14%$797.61M
AHGUSAkso Health
-21.58x--$402.97M
ACHUSAccendra Health
-0.27x89.03%$83.06M
COSMUSCosmos Health
-1.04x66.67%$25.48M
ZSTKUSZeroStack
-0.07x90.76%$11.91M
POMUSPomdoctor
-0.19x--$5.53M
MEDSUSDataMeds AI
-0.03x--$2.73M
ATPCUSAgape ATP
-2.09x--$2.37M
VRAXUSVirax Biolabs
-0.45x52.53%$2.27M
BIMIUSBIMI International Medical
----$6.98K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.